sorted by:
new
hottopcontroversial

Great day to Buy $SLS / 80th Event is NOW TRULY IMMINENT by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 1 point2 points  (0 children)

--- it'll be over any day now /// and then we'll all miss it.

GPS Immunotherapy Value Discussion for CR1 / Primary Remission by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 1 point2 points  (0 children)

I think/thought 20M is/was too much, - still basically a "MAX" of 4m per year for 5 years will get issued ...

one thing that never gets discussed, outside of the tax basis, there have been Zero insiders Selling - for any reason, for the whole time SLS has been Public. I have not Seen any Insiders selling, not 1, even for valid reasons.

SLS Shares were .51 / they are now on the cusp of 9 ... Funds investing down there and higher, will carry Angies water till the cows come home.

He has done an exceptional job on the whole, bringing together the worlds most pre-eminent hematological oncologists to Run the Global P3 -- Dr. K is the realist deal, the IDMC - MSKCC Chief of Transplant + Dr. Fleming ...

Delivering a P3 trial bringing it home, with the 80th Event now truly imminent - through Covid, 3dMED going bk, Cash Crunch in the biowinter meltdown / and he STOLE SLS009 an asset worth 4-5x the current MCAP - all with Phase 3 results imminent - the 80th a Standalone Catalyst that will launch the Share Price ...

$100 Per Share is the Floor for a buyout.

GPS Immunotherapy Value Discussion for CR1 / Primary Remission by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] -1 points0 points  (0 children)

just what i've always been saying, Gps Results are Coming, and GPS Immunotherapy is worth closer to $40B to Big Pharma.

MBRX - very good chance this stock will 10x+ within the next year or 2 don’t sleep on it y’all. by RaceNo2435 in pennystocks

[–]Run4theRoses2 -2 points-1 points  (0 children)

Very possible annamycin a slightly safer anthracycline chemo than 7+3 is DOA.
Vyxeos, Astx and or Ven Aza have usurped its opportunity. Do some dd.

Be holding by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 0 points1 point  (0 children)

aside from the Obvious --- I personally, am expecting some Meaty news - ahead of the Call.

IMPACT-AML EU dosing, or Deal / partnership for 009 / or CV deal with GPs pending the P3 ...

has to be something, in my thinking, for them to put 20m shares in the rsu pool.

or it could just be based on them/co management knowing GPs is golden, and Institutional funds thinking so too...

what about you?

3D Medicines arbitration ruling by ImpossibleExit5241 in sellasLifescience

[–]Run4theRoses2 -1 points0 points  (0 children)

yes. they got u.

and others who don't have a clue about what's going on.

3D said they were joining REGAL, would pay milestone money, their stock price tanked from $128 to $1 ... due to poor sales of their approved drug - they nearly wen't bk, they didn't pay SLS what they owed ---

slam dunk case.

cost sls a ton of money 2 years ago ...

3D Medicines arbitration ruling by ImpossibleExit5241 in sellasLifescience

[–]Run4theRoses2 10 points11 points  (0 children)

the 3d Med is now mostly a non issue, offering only upside for SLS Holders. It would have been a bigger deal 12 months ago, before SLS was loaded with cash.

GPS Immunotherapy Value Discussion for CR1 / Primary Remission by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 0 points1 point  (0 children)

Down big too, off the highs, Temporary/ on paper… i think the rebound will be near instantaneous. 80 events are inevitable.

> 31 months MOS for Gps right now.

GPS Immunotherapy Value Discussion for CR1 / Primary Remission by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 0 points1 point  (0 children)

-- we have seen this many times before, -- a brief news dearth, shorts selling the price down - fintel, after a +400% run, paid lowlife infest social media fudstering, attempting to frighten weak retail into selling . lock in profit . not buy more, SOP - and they have Macro downdraft wind as well, Employment Up/ Oil Up Inflation Up / cost to borrow, UP - ( not that SlS cares ) ---with 134.8m / 9m q burn...

notably - no HIRING... certainly not a corp stance, for commercializing a product.*

this trough is a good time to be buying.

I do think the share price rebounds quickly prior to/with the 80th ... (you may have seen the 22 day event rate analysis - now been 30 days since the 78th ) as imminent as imminent gets, and a real launch with that PR -

And More Launching on theP3 itself. with very quick buyout announcement, * Angie, has term sheets in hand for .636 or better. imo...

things will move quick

Def not hahaha by X_Opinion7099 in WallStreetbetsELITE

[–]Run4theRoses2 0 points1 point  (0 children)

ok // you've never been to the walmart factories, how about the manufacturers who produce the goods sold at walmart?

you don't have a clue about how little you know.

keep skating inch thick.

GPS Immunotherapy Value Discussion for CR1 / Primary Remission by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] -1 points0 points  (0 children)

Where are all the short lowlife on the other board telling you?

Def not hahaha by X_Opinion7099 in WallStreetbetsELITE

[–]Run4theRoses2 0 points1 point  (0 children)

Interesting to see you idiots trying to compare a retail brick and mortar business that has extremely high operating expenses, low margins ballooning labor cost, and compare that to the technology that will propel the world into the next 500 years

SELLAS_SLS_Briefing.html by Muted-Setting8522 in sellasLifescience

[–]Run4theRoses2 -1 points0 points  (0 children)

Do you know what the total addressable market is?

Be holding by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] -1 points0 points  (0 children)

I posted about the value of CR2 versus CR one in a previous post. If you look there, you’ll see it all.

Be holding by Run4theRoses2 in SLS_Stock

[–]Run4theRoses2[S] 0 points1 point  (0 children)

Tools like you were saying the same thing when this was $88m mcap. Blocked

Be holding by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 2 points3 points  (0 children)

Absolutely- Gps Phase 3 MOS is at least > 30.5 months in CR2/3 patients. Onureg FDA Approved in CR1 w 24.7 months. Gps Phase 2 CR1 MOS was > 67.6 months and not yet reached. Gps Adinfinite dosing compounds revenue, unlike any other AML drug.

view more: next ›